Collaborative Practice Agreement: Physician Referral for Comprehensive Medication Review and Assessment – Example 2Collaborative Practice Agreement • March 25th, 2015
Contract Type FiledMarch 25th, 2015Asthma is a complex medical condition which often requires close monitoring, medication management, drug dose titration, and patient/caregiver education. The National Heart Lung and Blood Institute (NHLBI), under the guidance of the National Institutes of Health (NIH), has published guidelines directing the care of patients with asthma.1 These guidelines recommend pharmacists be included as part of the care team to ensure patients achieve asthma control. [Insert Name of Pharmacy] is part of the Wisconsin Pharmacy Quality Collaborative2 which is committed to improving health outcomes and reducing health care costs by aligning with evidence-based guidelines. Participating pharmacies and their pharmacists must adhere to a set of quality standards3 designed to increase the quality of pharmacy services provided and maximize patient safety in the medication use process. The ultimate goal of WPQC is to resolve drug therapy problems, improve adherence, and engage patients in their own care. To